Neurocrine Biosciences, Inc. (NBIX)
Q2 2012 Earnings Call
July 31, 2012 5:00 p.m. ET
Kevin Gorman - President & Chief Executive Officer
Jane Sorenson - Investor Relations
Tim Coughlin - Vice President & Chief Financial Officer
Chris O'Brien - Chief Medical Officer
Thomas Wei - Jefferies
Ian Somaiya - Piper Jaffray
Phil Nadeau - Cowen & Company
Good day everyone and welcome to Neurocrine Biosciences Reports Second Quarter 2012 Results. At this time all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the Q&A session. (Operator Instructions) Please note that this cal is being recorded and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Kevin Gorman. Please go ahead.
Thank you very much and welcome everyone this afternoon to our mid-year earnings call. Before I get started I would like Jane Sorenson to read our Safe Harbor statement.
Good afternoon. I want to remind you of Neurocrine’s Safe Harbor caution. Certain statements made in the course of this conference call that state the company's or management's intentions, hopes, believes, expectations or predictions of the future are forward-looking statements which are subject to risks and uncertainties. Information concerning factors that could cause actual results to differ materially from those contained in or implied by the forward-looking statements is contained in the company's SEC filings, including but not limited to, the company's annual report on Form 10-K and quarterly reports on Form 10-Q.